Insider Transactions in Q2 2024 at Fennec Pharmaceuticals Inc. (FENC)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 03
2024
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
2,431
-1.28%
|
$14,586
$6.76 P/Share
|
|
May 31
2024
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+0.97%
|
-
|
|
May 31
2024
|
Rosty Raykov |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+1.26%
|
-
|
|
May 01
2024
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
2,431
-1.28%
|
$21,879
$9.11 P/Share
|
|
Apr 30
2024
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+0.98%
|
-
|
|
Apr 30
2024
|
Rosty Raykov |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+1.26%
|
-
|
|
Apr 22
2024
|
Adrian Haigh CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
22,223
-100.0%
|
$200,007
$9.32 P/Share
|
|
Apr 22
2024
|
Adrian Haigh CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
22,223
+50.0%
|
$44,446
$2.31 P/Share
|
|
Apr 19
2024
|
Adrian Haigh CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
22,222
-100.0%
|
$199,998
$9.34 P/Share
|
|
Apr 19
2024
|
Adrian Haigh CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
22,222
+50.0%
|
$44,444
$2.31 P/Share
|
|
Apr 18
2024
|
Adrian Haigh CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
22,222
-100.0%
|
$199,998
$9.62 P/Share
|
|
Apr 18
2024
|
Adrian Haigh CHIEF OPERATING OFFICER |
BUY
Open market or private sale
|
Direct |
22,222
+33.33%
|
$44,444
$2.31 P/Share
|
|
Apr 17
2024
|
Adrian Haigh CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
22,222
-50.0%
|
$199,998
$9.91 P/Share
|
|
Apr 17
2024
|
Adrian Haigh CHIEF OPERATING OFFICER |
BUY
Open market or private sale
|
Direct |
22,222
+50.0%
|
$44,444
$2.31 P/Share
|
|
Apr 16
2024
|
Adrian Haigh CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
22,222
-100.0%
|
$222,220
$10.28 P/Share
|
|
Apr 16
2024
|
Adrian Haigh CHIEF OPERATING OFFICER |
BUY
Open market or private sale
|
Direct |
22,222
+33.33%
|
$44,444
$2.31 P/Share
|
|
Apr 15
2024
|
Adrian Haigh CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
22,222
-50.0%
|
$222,220
$10.3 P/Share
|
|
Apr 15
2024
|
Adrian Haigh CHIEF OPERATING OFFICER |
BUY
Open market or private sale
|
Direct |
22,222
+50.0%
|
$44,444
$2.31 P/Share
|
|
Apr 15
2024
|
Chris A Rallis |
BUY
Exercise of conversion of derivative security
|
Direct |
1,389
+2.94%
|
$13,890
$10.45 P/Share
|
|
Apr 15
2024
|
Chris A Rallis |
SELL
Open market or private sale
|
Direct |
800
-1.77%
|
$8,000
$10.45 P/Share
|
|
Apr 05
2024
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
44,300
-19.11%
|
$443,000
$10.75 P/Share
|
|
Apr 04
2024
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
44,283
-8.32%
|
$442,830
$10.89 P/Share
|
|
Apr 03
2024
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
40,584
-6.61%
|
$405,840
$10.78 P/Share
|
|
Apr 01
2024
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
12,500
+10.7%
|
-
|
|
Apr 01
2024
|
Rosty Raykov |
BUY
Open market or private purchase
|
Direct |
29,167
+8.43%
|
-
|